1,3,4,4-Tetramethyl-5-[(E)-2-(3-nitrophenyl)ethenyl]-4H-pyrazol-1-ium iodide, 96.0%, 10mg

Molecular Sieve (1.6-2.5mm bead size) 3A Pore Size, 1kg

4,4'-(3',4',5',6'-Tetrakis(4-(pyridin-4-yl)phenyl)-[1,1':2',1''-terphenyl]-4,4''-diyl)dipyridine, 98%, 250mg

2,4-Difluoro-3-iodobenzaldehyde, 98%, 1g

3-Amino-N-methyl-2-pyrrolidinone, 97.0%, 100mg

(4R)-4-PHENYL-2-(2-PYRIDYL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

Piperazine-1-carboxylic acid amide hydrochloride, 98.0%, 250mg

Piperidine-2-carboxylic acid, 98.0%, 100g

4-[(tert-Butyldimethylsilyl)oxy]benzaldehyde, 96%, 1g

tert-Butyl (pyrimidin-2-ylmethyl)carbamate, 95.0%, 1g

LSD Inhibitor S1025>98.0%(HPLC)(qNMR)25mg

1-((tetrahydro-2H-pyran-4-yl)methyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

(ETHYL 2-(ETHOXYCARBONYLAMINO)-4-METHYL-5-(4-NITROPHENYL)THIOPHENE-3-CARBOXYLATE), 95%, 25g